NASDAQ: TXMD
Therapeuticsmd Inc Stock

$1.24+0.01 (+0.81%)
Updated Apr 30, 2025
TXMD Price
$1.24
Fair Value Price
-$1.22
Market Cap
$14.35M
52 Week Low
$0.70
52 Week High
$2.44
P/E
-6.53x
P/B
0.52x
P/S
5.63x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.76M
Earnings
-$2.18M
Gross Margin
100%
Operating Margin
-125.61%
Profit Margin
-123.9%
Debt to Equity
0.42
Operating Cash Flow
$732k
Beta
1.04
Next Earnings
May 8, 2025
Ex-Dividend
N/A
Next Dividend
N/A

TXMD Overview

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine TXMD's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Pharmaceutical

Industry Rating
B
TXMD
Ranked
Unranked of 57

Top Ranked Stocks in Industry

View Top Pharmaceutical Stocks

Be the first to know about important TXMD news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how TXMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TXMD ($1.24) is overvalued by 201.39% relative to our estimate of its Fair Value price of -$1.22 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
TXMD ($1.24) is not significantly undervalued (201.39%) relative to our estimate of its Fair Value price of -$1.22 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TXMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TXMD due diligence checks available for Premium users.

Valuation

TXMD fair value

Fair Value of TXMD stock based on Discounted Cash Flow (DCF)

Price
$1.24
Fair Value
-$1.22
Undervalued by
201.39%
TXMD ($1.24) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TXMD ($1.24) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TXMD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

TXMD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-6.53x
Industry
21.23x
Market
29.18x

TXMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.52x
Industry
2.09x
TXMD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TXMD's financial health

Profit margin

Revenue
$667.0k
Net Income
$252.0k
Profit Margin
37.8%
TXMD's Earnings (EBIT) of -$2.21M... subscribe to Premium to read more.
Interest Coverage Financials
TXMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$38.8M
Liabilities
$11.5M
Debt to equity
0.42
TXMD's short-term assets ($12.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TXMD's short-term assets ($12.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TXMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TXMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$12.0k
Investing
$0.0
Financing
$0.0
TXMD's operating cash flow ($732.00k)... subscribe to Premium to read more.
Debt Coverage Financials

TXMD vs Pharmaceutical Stocks

TickerZen RatingMarket Cap1d %P/EP/B
TXMD$14.35M+0.81%-6.53x0.52x
QNTMD$14.97M-4.96%-0.71x1.88x
FLGC$11.41M-2.17%-0.45x2.53x
DRRX$18.63M-3.23%-2.22x2.04x
SXTC$9.14M+6.36%0.02x0.61x

Therapeuticsmd Stock FAQ

What is Therapeuticsmd's quote symbol?

(NASDAQ: TXMD) Therapeuticsmd trades on the NASDAQ under the ticker symbol TXMD. Therapeuticsmd stock quotes can also be displayed as NASDAQ: TXMD.

If you're new to stock investing, here's how to buy Therapeuticsmd stock.

What is the 52 week high and low for Therapeuticsmd (NASDAQ: TXMD)?

(NASDAQ: TXMD) Therapeuticsmd's 52-week high was $2.44, and its 52-week low was $0.70. It is currently -49.18% from its 52-week high and 77.14% from its 52-week low.

How much is Therapeuticsmd stock worth today?

(NASDAQ: TXMD) Therapeuticsmd currently has 11,574,362 outstanding shares. With Therapeuticsmd stock trading at $1.24 per share, the total value of Therapeuticsmd stock (market capitalization) is $14.35M.

Therapeuticsmd stock was originally listed at a price of $1.20 in Dec 2, 2011. If you had invested in Therapeuticsmd stock at $1.20, your return over the last 13 years would have been 3.33%, for an annualized return of 0.25% (not including any dividends or dividend reinvestments).

How much is Therapeuticsmd's stock price per share?

(NASDAQ: TXMD) Therapeuticsmd stock price per share is $1.24 today (as of Apr 30, 2025).

What is Therapeuticsmd's Market Cap?

(NASDAQ: TXMD) Therapeuticsmd's market cap is $14.35M, as of May 1, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Therapeuticsmd's market cap is calculated by multiplying TXMD's current stock price of $1.24 by TXMD's total outstanding shares of 11,574,362.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.